Interim Report On The 36-month Clinical Outcomes From The First 500 Patients Enrolled In The ABSORB EXTEND Study

被引:1
|
作者
Bartorelli, Antonio L. [1 ]
机构
[1] Univ Milan, Milan, Italy
关键词
Bioresorbable scaffold;
D O I
10.1016/j.jacc.2015.08.520
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-503
引用
收藏
页码:B206 / B206
页数:1
相关论文
共 50 条
  • [21] 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma
    Greenwood, Michael D.
    Yadgarov, Arkadiy
    Flowers, Brian E.
    Sarkisian Jr, Steven R.
    Ohene-Nyako, Afua
    Dickerson Jr, Jaime E.
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 3817 - 3824
  • [22] RELATION BETWEEN BIORESORBABLE SCAFFOLD SIZING USING QCA-DMAX AND CLINICAL OUTCOMES AT 2 YEARS IN 1192 PATIENTS FROM THREE STUDY COHORTS (ABSORB COHORT B, ABSORB EXTEND AND ABSORB II)
    Onuma, Yoshinobu
    Sotomi, Yohei
    Suwannasom, Pannipa
    Bartorelli, Antonio
    Whitbourn, Robert
    Chevalier, Bernard
    Abizaid, Alexandre
    Ormiston, John
    Rapoza, Richard
    Veldhof, Susan
    Serruys, Patrick
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 425 - 425
  • [23] Tolerability of outpatient antipsychotic treatment:: 36-Month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, D.
    Haro, J. M.
    Suarez, D.
    Bushe, C.
    Lepine, J. P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S161 - S161
  • [24] Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, Diego
    Maria Haro, Josep
    Perrin, Elena
    Suarez, David
    Texeira, Joao Marques
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 542 - 550
  • [25] Clinical course, social functioning, quality of life & medication tolerability in previously untreated patients with schizophrenia: 36-month results from the European schizophrenia outpatient health outcomes (SOHO) study
    Novick, D.
    Suarez, D.
    Brown, J.
    Gasquet, I.
    Haro, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S387 - S388
  • [26] ADHERENCE WITH ANTIPSYCHOTIC TREATMENT MEDICATION IN OUTPATIENTS WITH SCHIZOPHRENIA: 36-MONTH RESULTS FROM THE SCHIZOPHRENIA OUTPATIENTS HEALTH OUTCOMES (SOHO) STUDY
    Novick, D.
    Suarez, D.
    Haro, J. M.
    Haddad, P. M.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [27] Effectiveness of different doses of olanzapine in outpatients with schizophrenia: 36-month results from the schizophrenia outpatients health outcomes (SOHO) study
    Novick, D.
    Deberdt, W.
    Haro, J. M.
    Suarez, D.
    Guerreiro, M.
    Laranjeira, L.
    Edlund, C.
    Marques-Teixeira, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S280 - S280
  • [28] ECONOMIC CONSEQUENCES OF MEDICATION NONADHERENCE IN THE TREATMENT OF SCHIZOPHRENIA: 36-MONTH RESULTS FROM THE SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY
    Hong, J.
    Novick, D.
    Haro, J. M.
    Knapp, M.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [29] Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
    Ishibashi, Yuki
    Nakatani, Shimpei
    Sotomi, Yohei
    Suwannasom, Pannipa
    Grundeken, Maik J.
    Garcia-Garcia, Hector M.
    Bartorelli, Antonio L.
    Whitbourn, Robert
    Chevalier, Bernard
    Abizaid, Alexandre
    Ormiston, John A.
    Rapoza, Richard J.
    Veldhof, Susan
    Onuma, Yoshinobu
    Serruys, Patrick W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (13) : 1715 - 1726
  • [30] Use of paliperidone palmitate in clinical practice: a 36-month follow-up study. From effectiveness to functional recovery
    Romero Guillena, S. L.
    Plasencia Garcia de Diego, B. O.
    De Ingunza Barreiro, E.
    Guillen Benitez, M.
    Gomez Gonzalez, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S501 - S501